Katsaros D - Search Results

1

[Expression and prognostic significance in epithelial ovarian cancer].

Katsaros D, Yu H, Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M. Katsaros D, et al. Minerva Ginecol. 2002 Feb;54(1):15-24. Minerva Ginecol. 2002. PMID: 11828267 Italian.

2

[Occult mammary lesions: preoperative localization. Review of the literature].

Volpe T, Katsaros D, Bergamino T, Rumore A, Zola P, Sismondi P. Volpe T, et al. Among authors: katsaros d. Minerva Ginecol. 1990 Oct;42(10):393-7. Minerva Ginecol. 1990. PMID: 2290595 Review. Italian.

3

Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary.

Yu H, Diamandis EP, Levesque M, Sismondi P, Zola P, Katsaros D. Yu H, et al. Among authors: katsaros d. J Clin Lab Anal. 1994;8(4):251-3. doi: 10.1002/jcla.1860080412. J Clin Lab Anal. 1994. PMID: 7523638

4

Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.

Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJ, Levesque MA, Roagna R, Ponzone R, Sismondi P. Yu H, et al. Among authors: katsaros d. Cancer Res. 1995 May 15;55(10):2104-10. Cancer Res. 1995. PMID: 7538047

5

Prostate-specific antigen in serum of women with breast cancer.

Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Levesque MA, Diamandis EP. Giai M, et al. Among authors: katsaros d. Br J Cancer. 1995 Sep;72(3):728-31. doi: 10.1038/bjc.1995.401. Br J Cancer. 1995. PMID: 7545417 Free PMC article.

6

Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.

Katsaros D, Theillet C, Zola P, Louason G, Sanfilippo B, Isaia E, Arisio R, Giardina G, Sismondi P. Katsaros D, et al. Anticancer Res. 1995 Jul-Aug;15(4):1501-10. Anticancer Res. 1995. PMID: 7654038

7

Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma.

Levesque MA, Katsaros D, Yu H, Zola P, Sismondi P, Giardina G, Diamandis EP. Levesque MA, et al. Among authors: katsaros d. Cancer. 1995 Mar 15;75(6):1327-38. doi: 10.1002/1097-0142(19950315)75:6<1327::aid-cncr2820750615>3.0.co;2-p. Cancer. 1995. PMID: 7882283

8

Overexpression of the Met/HGF receptor in ovarian cancer.

Di Renzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P, Sismondi P, Comoglio PM. Di Renzo MF, et al. Among authors: katsaros d. Int J Cancer. 1994 Sep 1;58(5):658-62. doi: 10.1002/ijc.2910580507. Int J Cancer. 1994. PMID: 8077049

9

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.

Bartlett JM, Langdon SP, Simpson BJ, Stewart M, Katsaros D, Sismondi P, Love S, Scott WN, Williams AR, Lessells AM, Macleod KG, Smyth JF, Miller WR. Bartlett JM, et al. Among authors: katsaros d. Br J Cancer. 1996 Feb;73(3):301-6. doi: 10.1038/bjc.1996.53. Br J Cancer. 1996. PMID: 8562334 Free PMC article.

10

Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.

Zarghami N, Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Sismondi P, Diamandis EP. Zarghami N, et al. Among authors: katsaros d. Br J Cancer. 1996 Feb;73(3):386-90. doi: 10.1038/bjc.1996.66. Br J Cancer. 1996. PMID: 8562347 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters